{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "19862729",
  "DateCompleted": {
    "Year": "2010",
    "Month": "01",
    "Day": "12"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "12",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "ger"
    ],
    "ELocationID": [
      "10.1002/pauz.200900346"
    ],
    "Journal": {
      "ISSN": "1615-1003",
      "JournalIssue": {
        "Volume": "38",
        "Issue": "6",
        "PubDate": {
          "Year": "2009"
        }
      },
      "Title": "Pharmazie in unserer Zeit",
      "ISOAbbreviation": "Pharm Unserer Zeit"
    },
    "ArticleTitle": "[Successful concept: proteases as targets for anti-infectives. New targets in the treatment of infection].",
    "Pagination": {
      "StartPage": "564",
      "EndPage": "577",
      "MedlinePgn": "564-74; quiz 576-7"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institut f. Pharmazie und LMC, Universit\u00e4t W\u00fcrzburg, Am Hubland, 97074 W\u00fcrzburg. Schirmei@pharmazie.uni-wuerzburg.de"
          }
        ],
        "LastName": "Schirmeister",
        "ForeName": "Tanja",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Welker",
        "ForeName": "Armin",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ],
    "VernacularTitle": "Erfolgreiches Konzept: Proteasen als Zielstrukturen f\u00fcr Antiinfektiva. Neue Angriffspunkte in der Infektionstherapie."
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Pharm Unserer Zeit",
    "NlmUniqueID": "0337763",
    "ISSNLinking": "0048-3664"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antimalarials"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiparasitic Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Protease Inhibitors"
    },
    {
      "RegistryNumber": "EC 3.4.-",
      "NameOfSubstance": "Peptide Hydrolases"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Antimalarials"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Antiparasitic Agents"
    },
    {
      "QualifierName": [
        "trends"
      ],
      "DescriptorName": "Drug Discovery"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Infections"
    },
    {
      "QualifierName": [
        "chemistry"
      ],
      "DescriptorName": "Peptide Hydrolases"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Protease Inhibitors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Protein Conformation"
    }
  ],
  "NumberOfReferences": "13"
}